HIV-1 Genetic Diversity and Drug Resistance Mutations Among Treatment-Naive Adult Patients in Suriname - Archive ouverte HAL Access content directly
Journal Articles AIDS Research and Human Retroviruses Year : 2016

HIV-1 Genetic Diversity and Drug Resistance Mutations Among Treatment-Naive Adult Patients in Suriname

(1) , (2) , (3) , (3) , (4) , (3)
1
2
3
4

Abstract

The molecular epidemiologic profile of HIV-1 in Suriname was determined through protease (PR) and reverse transcriptase (RT) sequences obtained from HIV-1 strains collected from 100 drug-naive HIV-1-infected persons. Subtype determination revealed that most viruses were of subtype B (94.9%) in both PR and RT genomic regions, followed by B/D recombinants (5.1%). Analysis of drug resistance mutations showed only one transmitted dug resistance mutation (TDRM) (V75M) in a single strain. The genetic data obtained can serve as a baseline for Suriname to monitor emerging mutations. This study reveals that the HIV-1 epidemic in Suriname is still characterized by a low TDRM rate (1%) and a low level of subtype diversity. However, both genes display a high genetic polymorphism. This high polymorphism may ultimately lead to drug resistance. Continuous monitoring of the baseline resistance is therefore a prerequisite to safeguard effective long-term treatment for people living with HIV-1 in Suriname.
Fichier principal
Vignette du fichier
HIV-1 Genetic Diversity and Drug Resistance.pdf (445.56 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

pasteur-02197614 , version 1 (06-04-2020)

Identifiers

Cite

Firoz Abdoel Wahid, Rachel Sno, Edith Darcissac, Anne Lavergne, Malti Adhin, et al.. HIV-1 Genetic Diversity and Drug Resistance Mutations Among Treatment-Naive Adult Patients in Suriname. AIDS Research and Human Retroviruses, 2016, 32 (12), pp.1223-1228. ⟨10.1089/AID.2016.0161⟩. ⟨pasteur-02197614⟩

Collections

RIIP RIIP_GUYANE
81 View
144 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More